Sheikha Moza Engages in Dialogue on Precision Health in Clinical Practice

Sheikha Moza Engages in Dialogue on Precision Health in Clinical Practice

Doha, The Gulf Observer: Today, Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation, graced a significant event at Education City, where the Qatar Precision Health Institute (QPHI) was officially inaugurated. Her presence underscored the nation’s commitment to advancing healthcare through personalized medicine. The ceremony also featured a panel discussion, moderated by Dr. Wadha Al Muftah, Senior Director of Qatar Genome at QPHI, delving into the pivotal role of personalized medicine in clinical practice.

The panel convened esteemed experts and leaders from Qatar’s healthcare sector to deliberate on various facets of personalized medicine adoption. Discussions traversed the support mechanisms bolstering Qatar’s stride towards personalized healthcare, the integration of precision health methodologies into clinical frameworks, and strategies for fostering collaboration and knowledge exchange within the healthcare domain. Dr. Salha Bujassoum, Senior Medical Oncologist at Hamad Medical Corporation’s National Centre for Cancer Care and Research, and Assistant Chair of Precision Medicine Committee at HMC, was among the distinguished speakers. She emphasized the significance of precision health applications in early cancer detection, shedding light on the transformative potential of proactive measures in disease prevention.

Dr. Bujassoum elucidated, “Tumors represent a significant share of genetic diseases, with 95% manifesting as genetic anomalies within affected organs. Through synergistic alliances with scientific entities like QPHI’s Qatar Biobank and the Qatar Genome Programme, we are pioneering preemptive interventions to thwart disease onset. Individuals identified with genetic mutations predisposing them to cancer, via participation in Qatar Biobank, are proactively engaged to adopt preventive measures before symptoms manifest. Precision health transcends treatment paradigms; it encompasses robust preventive strategies.”

The event served as a rallying point for stakeholders invested in revolutionizing healthcare delivery through personalized medicine. It epitomized Qatar’s unwavering commitment to leveraging cutting-edge technologies and collaborative frameworks to usher in a new era of healthcare excellence, where prevention and treatment converge seamlessly. The official launch of Qatar Precision Health Institute stands as a testament to the nation’s resolve in championing innovative solutions that resonate with global healthcare imperatives.